Quadrant Capital Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,900
| Closed | -$34K | – | 2542 |
|
|
2025
Q1 | $34K | Buy |
3,900
+3,748
| +2,466% | +$32.7K | ﹤0.01% | 1855 |
|
|
2024
Q4 | $2.18K | Sell |
152
-102
| -40% | -$1.47K | ﹤0.01% | 2485 |
|
|
2024
Q3 | $5.74K | Buy |
254
+226
| +807% | +$5.1K | ﹤0.01% | 2291 |
|
|
2024
Q2 | $545 | Sell |
28
-67
| -71% | -$1.3K | ﹤0.01% | 2612 |
|
|
2024
Q1 | $3.57K | Sell |
95
-55
| -37% | -$2.07K | ﹤0.01% | 2392 |
|
|
2023
Q4 | $8.39K | Buy |
150
+1
| +0.7% | +$56 | ﹤0.01% | 2132 |
|
|
2023
Q3 | $6.15K | Hold |
149
| – | – | ﹤0.01% | 2120 |
|
|
2023
Q2 | $8.32K | Hold |
149
| – | – | ﹤0.01% | 2071 |
|
|
2023
Q1 | $8.31K | Sell |
149
-82
| -35% | -$4.58K | ﹤0.01% | 2101 |
|
|
2022
Q4 | $8.42K | Buy |
231
+117
| +103% | +$4.26K | ﹤0.01% | 2037 |
|
|
2022
Q3 | $3K | Buy |
114
+66
| +138% | +$1.74K | ﹤0.01% | 2302 |
|
|
2022
Q2 | $2K | Sell |
48
-51
| -52% | -$2.13K | ﹤0.01% | 2284 |
|
|
2022
Q1 | $8K | Buy |
99
+1
| +1% | +$81 | ﹤0.01% | 1760 |
|
|
2021
Q4 | $15K | Buy |
98
+36
| +58% | +$5.51K | ﹤0.01% | 1454 |
|
|
2021
Q3 | $9K | Buy |
62
+4
| +7% | +$581 | ﹤0.01% | 1662 |
|
|
2021
Q2 | $11K | Sell |
58
-43
| -43% | -$8.16K | ﹤0.01% | 1524 |
|
|
2021
Q1 | $18K | Buy |
101
+50
| +98% | +$8.91K | ﹤0.01% | 1238 |
|
|
2020
Q4 | $7K | Buy |
+51
| New | +$7K | ﹤0.01% | 1595 |
|
|
2020
Q3 | – | Sell |
-151
| Closed | -$13K | – | 2311 |
|
|
2020
Q2 | $13K | Buy |
+151
| New | +$13K | ﹤0.01% | 1228 |
|